Annual SG&A
$19.71 M
-$2.00 M-9.23%
31 December 2023
Summary:
NextCure annual selling, general & administrative expenses is currently $19.71 million, with the most recent change of -$2.00 million (-9.23%) on 31 December 2023. During the last 3 years, it has risen by +$2.66 million (+15.58%). NXTC annual SG&A is now -9.23% below its all-time high of $21.71 million, reached on 31 December 2022.NXTC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.73 M
-$351.00 K-8.61%
30 September 2024
Summary:
NextCure quarterly selling, general & administrative expenses is currently $3.73 million, with the most recent change of -$351.00 thousand (-8.61%) on 30 September 2024. Over the past year, it has dropped by -$883.00 thousand (-19.16%). NXTC quarterly SG&A is now -37.99% below its all-time high of $6.01 million, reached on 30 June 2021.NXTC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.39 B
-$58.52 M-4.39%
30 September 2024
Summary:
NextCure TTM selling, general & administrative expenses is currently -$1.39 billion, with the most recent change of -$58.52 million (-4.39%) on 30 September 2024. Over the past year, it has dropped by -$1.41 billion (-6825.29%). NXTC TTM SG&A is now -2842.25% below its all-time high of $21.80 million, reached on 30 June 2023.NXTC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NXTC Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.2% | -19.2% | -6825.3% |
| 3 y3 years | +15.6% | -24.1% | -7094.0% |
| 5 y5 years | +478.1% | +42.1% | -10000.0% |
NXTC Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.2% | +15.6% | -35.2% | at low | -142.4% | at low |
| 5 y | 5 years | -9.2% | +478.1% | -38.0% | +42.3% | -498.5% | at low |
| alltime | all time | -9.2% | +659.4% | -38.0% | +366.2% | -2842.3% | at low |
NextCure Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.73 M(-8.6%) | $16.13 M(-5.2%) |
| June 2024 | - | $4.08 M(-6.6%) | $17.01 M(-8.8%) |
| Mar 2024 | - | $4.36 M(+10.1%) | $18.65 M(-5.4%) |
| Dec 2023 | $19.71 M(-9.2%) | $3.96 M(-14.0%) | $19.71 M(-4.8%) |
| Sept 2023 | - | $4.61 M(-19.3%) | $20.69 M(-5.1%) |
| June 2023 | - | $5.71 M(+5.3%) | $21.80 M(+1.9%) |
| Mar 2023 | - | $5.42 M(+9.6%) | $21.39 M(-1.5%) |
| Dec 2022 | $21.71 M(+5.5%) | $4.95 M(-13.3%) | $21.71 M(+0.7%) |
| Sept 2022 | - | $5.71 M(+7.7%) | $21.57 M(+3.9%) |
| June 2022 | - | $5.30 M(-7.7%) | $20.77 M(-3.3%) |
| Mar 2022 | - | $5.75 M(+19.6%) | $21.47 M(+4.4%) |
| Dec 2021 | $20.57 M | $4.81 M(-2.1%) | $20.57 M(+3.4%) |
| Sept 2021 | - | $4.91 M(-18.2%) | $19.90 M(+1.3%) |
| June 2021 | - | $6.01 M(+23.9%) | $19.64 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $4.85 M(+17.4%) | $18.31 M(+7.4%) |
| Dec 2020 | $17.05 M(+77.4%) | $4.13 M(-11.3%) | $17.05 M(+9.7%) |
| Sept 2020 | - | $4.66 M(-0.3%) | $15.54 M(+15.1%) |
| June 2020 | - | $4.67 M(+30.2%) | $13.50 M(+17.0%) |
| Mar 2020 | - | $3.59 M(+37.1%) | $11.54 M(+20.1%) |
| Dec 2019 | $9.61 M(+182.0%) | $2.62 M(-0.2%) | $9.61 M(+23.0%) |
| Sept 2019 | - | $2.62 M(-3.4%) | $7.81 M(+27.7%) |
| June 2019 | - | $2.71 M(+63.6%) | $6.12 M(+43.3%) |
| Mar 2019 | - | $1.66 M(+102.6%) | $4.27 M(+25.2%) |
| Dec 2018 | $3.41 M(+31.4%) | $819.00 K(-11.5%) | $3.41 M(+31.6%) |
| Sept 2018 | - | $925.00 K(+6.8%) | $2.59 M(+55.6%) |
| June 2018 | - | $866.00 K(+8.4%) | $1.67 M(+108.4%) |
| Mar 2018 | - | $799.00 K | $799.00 K |
| Dec 2017 | $2.60 M | - | - |
FAQ
- What is NextCure annual selling, general & administrative expenses?
- What is the all time high annual SG&A for NextCure?
- What is NextCure annual SG&A year-on-year change?
- What is NextCure quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for NextCure?
- What is NextCure quarterly SG&A year-on-year change?
- What is NextCure TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for NextCure?
- What is NextCure TTM SG&A year-on-year change?
What is NextCure annual selling, general & administrative expenses?
The current annual SG&A of NXTC is $19.71 M
What is the all time high annual SG&A for NextCure?
NextCure all-time high annual selling, general & administrative expenses is $21.71 M
What is NextCure annual SG&A year-on-year change?
Over the past year, NXTC annual selling, general & administrative expenses has changed by -$2.00 M (-9.23%)
What is NextCure quarterly selling, general & administrative expenses?
The current quarterly SG&A of NXTC is $3.73 M
What is the all time high quarterly SG&A for NextCure?
NextCure all-time high quarterly selling, general & administrative expenses is $6.01 M
What is NextCure quarterly SG&A year-on-year change?
Over the past year, NXTC quarterly selling, general & administrative expenses has changed by -$883.00 K (-19.16%)
What is NextCure TTM selling, general & administrative expenses?
The current TTM SG&A of NXTC is -$1.39 B
What is the all time high TTM SG&A for NextCure?
NextCure all-time high TTM selling, general & administrative expenses is $21.80 M
What is NextCure TTM SG&A year-on-year change?
Over the past year, NXTC TTM selling, general & administrative expenses has changed by -$1.41 B (-6825.29%)